Disclosures for "Risk Factors Associated with Disability and Recurrence of Relapses in Patients with Neuromyelitis Optica Spectrum Disorders (NMOSD) Attended in a Neuroinmunology Unit of a Therthiary Health Care Center at the Dominican Republic During October 2024-January 2025.-"
-
Dr. Santos de Pena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Mesofarma Corporation y Novartis .
-
Dr. Mejia has nothing to disclose.
-
Dr. ALVARES has nothing to disclose.
-
Dr. Sierra has nothing to disclose.